Sexually Transmitted Diseases (STD) Diagnostics Market Size, Share, and Outlook, H2-2025 Report- By Disease (CT/NG, Gonorrhea, HIV/AIDS, Genital Herpes, Hepatitis B, Syphilis, Mycoplasma Genitalium, Genital Warts, Candidal Vaginitis, Trichomoniasis, Bacte
Description
Sexually Transmitted Diseases (STD) Diagnostics Market Outlook
The global Sexually Transmitted Diseases (STD) Diagnostics Market Size is valued at $90.4 Billion in 2025 and is forecast to reach $134.1 Billion in 2032 at a CAGR of 5.8%.
The Sexually Transmitted Diseases (STD) Diagnostics Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Sexually Transmitted Diseases (STD) Diagnostics Market segments across 22 countries from 2021 to 2032. Key segments covered include By Disease (CT/NG, Gonorrhea, HIV/AIDS, Genital Herpes, Hepatitis B, Syphilis, Mycoplasma Genitalium, Genital Warts, Candidal Vaginitis, Trichomoniasis, Bacterial Vaginosis, HPV, Others), By Test (Culture/Isolation Of Organisms, Molecular Test, Immunology Assay, Others), By Device (Laboratory Devices, Point Of Care (Poc) Devices), By End-User (Laboratory, Point of Care (POC)), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Sexually Transmitted Diseases (STD) Diagnostics Market Insights, 2025
The STD diagnostics market in 2025 is advancing with rapid point-of-care tests, nucleic acid amplification assays, and multiplex platforms for simultaneous detection of multiple infections. Innovations include smartphone-integrated diagnostics, self-sampling kits, and AI-assisted result interpretation. Regulatory frameworks ensure assay sensitivity, specificity, and patient safety. Research focuses on early detection, reducing false negatives, and expanding testing in low-resource settings. Adoption is growing in sexual health clinics, public health programs, and home-testing channels. Integration with digital health platforms enables secure reporting and patient follow-up. Overall, the market reflects rapid diagnostics, accessibility, and public health-focused innovations in STI management.
Five Trends Shaping the Global Sexually Transmitted Diseases (STD) Diagnostics Market in 2025 and Beyond
The global Sexually Transmitted Diseases (STD) Diagnostics Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Sexually Transmitted Diseases (STD) Diagnostics Industry?
The Sexually Transmitted Diseases (STD) Diagnostics Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Sexually Transmitted Diseases (STD) Diagnostics Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Sexually Transmitted Diseases (STD) Diagnostics Market Segment Insights
The Sexually Transmitted Diseases (STD) Diagnostics Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Disease (CT/NG, Gonorrhea, HIV/AIDS, Genital Herpes, Hepatitis B, Syphilis, Mycoplasma Genitalium, Genital Warts, Candidal Vaginitis, Trichomoniasis, Bacterial Vaginosis, HPV, Others), By Test (Culture/Isolation Of Organisms, Molecular Test, Immunology Assay, Others), By Device (Laboratory Devices, Point Of Care (Poc) Devices), By End-User (Laboratory, Point of Care (POC)). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Sexually Transmitted Diseases (STD) Diagnostics Industry Value Chain
The chapter identifies potential companies and their operations across the global Sexually Transmitted Diseases (STD) Diagnostics Industry ecosystem. It assists decision-makers in evaluating global Sexually Transmitted Diseases (STD) Diagnostics Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Sexually Transmitted Diseases (STD) Diagnostics Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Sexually Transmitted Diseases (STD) Diagnostics Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Sexually Transmitted Diseases (STD) Diagnostics Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Sexually Transmitted Diseases (STD) Diagnostics Market.
Europe Sexually Transmitted Diseases (STD) Diagnostics Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Sexually Transmitted Diseases (STD) Diagnostics Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Sexually Transmitted Diseases (STD) Diagnostics Industry competitiveness. The report analyses the key Sexually Transmitted Diseases (STD) Diagnostics Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Sexually Transmitted Diseases (STD) Diagnostics Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Sexually Transmitted Diseases (STD) Diagnostics Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Sexually Transmitted Diseases (STD) Diagnostics Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Sexually Transmitted Diseases (STD) Diagnostics Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Sexually Transmitted Diseases (STD) Diagnostics Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Sexually Transmitted Diseases (STD) Diagnostics Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, bioMérieux SA, Bi-Rad Laboratories Inc, Danaher Corp, DiaSorin S.p.A, F. Hoffmann-La Roche Ltd, Grifols S.A., Hologic Inc, QIAGEN NV, Quidel Corp, Thermo Fisher Scientific Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Sexually Transmitted Diseases (STD) Diagnostics Market Scope
Leading Segments
By Disease
CT/NG
Gonorrhea
HIV/AIDS
Genital Herpes
Hepatitis B
Syphilis
Mycoplasma Genitalium
Genital Warts
Candidal Vaginitis
Trichomoniasis
Bacterial Vaginosis
HPV
Others
By Test
Culture/Isolation Of Organisms
Molecular Test
Immunology Assay
Others
By Device
Laboratory DevicesThermal Cyclers – PCR Lateral Flow Readers Flow Cytometers Absorbance Microplate Reader Differential Light Scattering Machines
Point Of Care (Poc) DevicesPhone Chips (Microfluidics + ICT) Portable/Bench Top/Rapid Diagnostic Kits
By End-User
LaboratoryCommerical/Private Labs Public Health Labs
Point of Care (POC)
Leading Companies
Abbott Laboratories
bioMérieux SA
Bi-Rad Laboratories Inc
Danaher Corp
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Grifols S.A.
Hologic Inc
QIAGEN NV
Quidel Corp
Thermo Fisher Scientific Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Sexually Transmitted Diseases (STD) Diagnostics Market Size is valued at $90.4 Billion in 2025 and is forecast to reach $134.1 Billion in 2032 at a CAGR of 5.8%.
The Sexually Transmitted Diseases (STD) Diagnostics Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Sexually Transmitted Diseases (STD) Diagnostics Market segments across 22 countries from 2021 to 2032. Key segments covered include By Disease (CT/NG, Gonorrhea, HIV/AIDS, Genital Herpes, Hepatitis B, Syphilis, Mycoplasma Genitalium, Genital Warts, Candidal Vaginitis, Trichomoniasis, Bacterial Vaginosis, HPV, Others), By Test (Culture/Isolation Of Organisms, Molecular Test, Immunology Assay, Others), By Device (Laboratory Devices, Point Of Care (Poc) Devices), By End-User (Laboratory, Point of Care (POC)), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Sexually Transmitted Diseases (STD) Diagnostics Market Insights, 2025
The STD diagnostics market in 2025 is advancing with rapid point-of-care tests, nucleic acid amplification assays, and multiplex platforms for simultaneous detection of multiple infections. Innovations include smartphone-integrated diagnostics, self-sampling kits, and AI-assisted result interpretation. Regulatory frameworks ensure assay sensitivity, specificity, and patient safety. Research focuses on early detection, reducing false negatives, and expanding testing in low-resource settings. Adoption is growing in sexual health clinics, public health programs, and home-testing channels. Integration with digital health platforms enables secure reporting and patient follow-up. Overall, the market reflects rapid diagnostics, accessibility, and public health-focused innovations in STI management.
Five Trends Shaping the Global Sexually Transmitted Diseases (STD) Diagnostics Market in 2025 and Beyond
The global Sexually Transmitted Diseases (STD) Diagnostics Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Sexually Transmitted Diseases (STD) Diagnostics Industry?
The Sexually Transmitted Diseases (STD) Diagnostics Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Sexually Transmitted Diseases (STD) Diagnostics Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Sexually Transmitted Diseases (STD) Diagnostics Market Segment Insights
The Sexually Transmitted Diseases (STD) Diagnostics Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Disease (CT/NG, Gonorrhea, HIV/AIDS, Genital Herpes, Hepatitis B, Syphilis, Mycoplasma Genitalium, Genital Warts, Candidal Vaginitis, Trichomoniasis, Bacterial Vaginosis, HPV, Others), By Test (Culture/Isolation Of Organisms, Molecular Test, Immunology Assay, Others), By Device (Laboratory Devices, Point Of Care (Poc) Devices), By End-User (Laboratory, Point of Care (POC)). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Sexually Transmitted Diseases (STD) Diagnostics Industry Value Chain
The chapter identifies potential companies and their operations across the global Sexually Transmitted Diseases (STD) Diagnostics Industry ecosystem. It assists decision-makers in evaluating global Sexually Transmitted Diseases (STD) Diagnostics Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Sexually Transmitted Diseases (STD) Diagnostics Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Sexually Transmitted Diseases (STD) Diagnostics Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Sexually Transmitted Diseases (STD) Diagnostics Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Sexually Transmitted Diseases (STD) Diagnostics Market.
Europe Sexually Transmitted Diseases (STD) Diagnostics Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Sexually Transmitted Diseases (STD) Diagnostics Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Sexually Transmitted Diseases (STD) Diagnostics Industry competitiveness. The report analyses the key Sexually Transmitted Diseases (STD) Diagnostics Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Sexually Transmitted Diseases (STD) Diagnostics Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Sexually Transmitted Diseases (STD) Diagnostics Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Sexually Transmitted Diseases (STD) Diagnostics Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Sexually Transmitted Diseases (STD) Diagnostics Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Sexually Transmitted Diseases (STD) Diagnostics Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Sexually Transmitted Diseases (STD) Diagnostics Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, bioMérieux SA, Bi-Rad Laboratories Inc, Danaher Corp, DiaSorin S.p.A, F. Hoffmann-La Roche Ltd, Grifols S.A., Hologic Inc, QIAGEN NV, Quidel Corp, Thermo Fisher Scientific Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Sexually Transmitted Diseases (STD) Diagnostics Market Scope
Leading Segments
By Disease
CT/NG
Gonorrhea
HIV/AIDS
Genital Herpes
Hepatitis B
Syphilis
Mycoplasma Genitalium
Genital Warts
Candidal Vaginitis
Trichomoniasis
Bacterial Vaginosis
HPV
Others
By Test
Culture/Isolation Of Organisms
Molecular Test
Immunology Assay
Others
By Device
Laboratory Devices
Point Of Care (Poc) Devices
By End-User
Laboratory
Point of Care (POC)
Leading Companies
Abbott Laboratories
bioMérieux SA
Bi-Rad Laboratories Inc
Danaher Corp
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Grifols S.A.
Hologic Inc
QIAGEN NV
Quidel Corp
Thermo Fisher Scientific Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
188 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Sexually Transmitted Diseases (STD) Diagnostics Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Sexually Transmitted Diseases (STD) Diagnostics Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Sexually Transmitted Diseases (STD) Diagnostics Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Sexually Transmitted Diseases (STD) Diagnostics Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Sexually Transmitted Diseases (STD) Diagnostics Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Disease
- CT/NG
- Gonorrhea
- HIV/AIDS
- Genital Herpes
- Hepatitis B
- Syphilis
- Mycoplasma Genitalium
- Genital Warts
- Candidal Vaginitis
- Trichomoniasis
- Bacterial Vaginosis
- HPV
- Others
- By Test
- Culture/Isolation Of Organisms
- Molecular Test
- Immunology Assay
- Others
- By Device
- Laboratory Devices
- -Thermal Cyclers – PCR
- -Lateral Flow Readers
- -Flow Cytometers
- -Absorbance Microplate Reader
- -Differential Light Scattering Machines
- Point Of Care (Poc) Devices
- -Phone Chips (Microfluidics + ICT)
- -Portable/Bench Top/Rapid Diagnostic Kits
- By End-User
- Laboratory
- -Commerical/Private Labs
- -Public Health Labs
- Point of Care (POC)
- 6. Global Sexually Transmitted Diseases (STD) Diagnostics Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Sexually Transmitted Diseases (STD) Diagnostics Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Sexually Transmitted Diseases (STD) Diagnostics Market Trends and Growth Opportunities
- 6.2.1 North America Sexually Transmitted Diseases (STD) Diagnostics Market Outlook by Type
- 6.2.2 North America Sexually Transmitted Diseases (STD) Diagnostics Market Outlook by Application
- 6.3 North America Sexually Transmitted Diseases (STD) Diagnostics Market Outlook by Country
- 6.3.1 The US Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 6.3.2 Canada Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 6.3.3 Mexico Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 7. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Trends and Growth Opportunities
- 7.2.1 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Outlook by Type
- 7.2.2 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Outlook by Application
- 7.3 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Outlook by Country
- 7.3.2 Germany Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 7.3.3 France Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 7.3.4 The UK Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 7.3.5 Spain Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 7.3.6 Italy Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 7.3.7 Russia Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 8. Asia Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Outlook by Type
- 8.2.2 Asia Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Outlook by Application
- 8.3 Asia Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Outlook by Country
- 8.3.1 China Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 8.3.2 India Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 8.3.3 Japan Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 8.3.4 South Korea Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 8.3.5 Australia Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 8.3.6 South East Asia Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 9. South America Sexually Transmitted Diseases (STD) Diagnostics Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Sexually Transmitted Diseases (STD) Diagnostics Market Trends and Growth Opportunities
- 9.2.1 South America Sexually Transmitted Diseases (STD) Diagnostics Market Outlook by Type
- 9.2.2 South America Sexually Transmitted Diseases (STD) Diagnostics Market Outlook by Application
- 9.3 South America Sexually Transmitted Diseases (STD) Diagnostics Market Outlook by Country
- 9.3.1 Brazil Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 9.3.2 Argentina Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 10. Middle East and Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Sexually Transmitted Diseases (STD) Diagnostics Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Sexually Transmitted Diseases (STD) Diagnostics Market Outlook by Type
- 10.2.2 Middle East and Africa Sexually Transmitted Diseases (STD) Diagnostics Market Outlook by Application
- 10.3 Middle East and Africa Sexually Transmitted Diseases (STD) Diagnostics Market Outlook by Country
- 10.3.1 Saudi Arabia Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 10.3.2 The UAE Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 10.3.4 South Africa Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 10.3.5 Egypt Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Sexually Transmitted Diseases (STD) Diagnostics Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Abbott Laboratories
- bioMérieux SA
- Bi-Rad Laboratories Inc
- Danaher Corp
- DiaSorin S.p.A
- F. Hoffmann-La Roche Ltd
- Grifols S.A.
- Hologic Inc
- QIAGEN NV
- Quidel Corp
- Thermo Fisher Scientific Inc
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
